More new therapies under study for underarm sweat
|
Qbrexza was approved earlier this year for primary axillary hyperhidrosis. And, now, other treatments are under study. In his presentation at this week’s Fall Clinical Dermatology Conference in Las Vegas, Dr. David Pariser summarizes the latest research. |
|
Cosmeceutical therapies on the horizon
|
In a presentation at the Fall Clinical Dermatology Conference held on Saturday in Las Vegas, Diane Berson, M.D., outlined trends and new ingredients in oral and topical cosmeceuticals. |